Interactive Tumor Panel: Clinical Investigators Discuss Emerging Research and Actual Cases of Patients with Breast Cancer


Interactive Tumor Panel: Clinical Investigators Discuss Emerging Research and Actual Cases of Patients
with Breast Cancer
Proceedings from a CME symposium held at the 2019 ASCO Annual Meeting. Featuring perspectives from Prof Fabrice André and Drs Virginia Kaklamani, Mark D Pegram, Hope S Rugo, Sara M Tolaney and Tiffany A Traina.
2.75 AMA PRA Category 1 Credits™
To complete the Post-test and Educational Assessment and Credit Form, click here. A statement of CME credit will be issued for scores of 80% or better. Your statement of credit will be mailed to you within 3 weeks or may be printed online.

Introduction

Available and Emerging Data Sets Shaping the Management of Localized HER2-Positive Breast Cancer (BC)

Use of Genomic Classifiers in Clinical Decision-Making for Patients with ER-Positive Early BC

Selection and Sequence of Therapy for ER-Positive, HER2-Negative Metastatic BC (mBC); Novel Agents and Strategies Under Evaluation in ER-Positive Disease

Immunotherapy as a Rational Therapeutic Strategy in BC

Protocol and Off-Protocol Decision-Making for Patients with HER2-Positive mBC

Role of PARP Inhibitors, Novel Agents in mBC; Male Breast Cancer